CAJ | 학술논문

胰腺癌治疗效果差,其重要原因就是早期诊断率低.血清肿瘤标志物以其独特的优势成为筛查胰腺癌患者最理想的检测方法.随着蛋白组学的发展,研究发现了很多新的血清肿瘤标志物,如载脂蛋白Apo A- Ⅱ、Apo C-Ⅰ、MBL2、MLCK2、REG4蛋白等.本文将就胰腺癌血清肿瘤标志物的研究进展作一综述.
이선암치료효과차,기중요원인취시조기진단솔저.혈청종류표지물이기독특적우세성위사사이선암환자최이상적검측방법.수착단백조학적발전,연구발현료흔다신적혈청종류표지물,여재지단백Apo A- Ⅱ、Apo C-Ⅰ、MBL2、MLCK2、REG4단백등.본문장취이선암혈청종류표지물적연구진전작일종술.
Pancreatic cancer has a bad curative effect because of low rate of early diagnosis.Plasma cancer marker becomes the most ideal screening method for the special advantages.With the development of proteomics,many new plasma cancer markers,such as apolipoprotei A-Ⅱ,apolipoprotei C-Ⅰ,MBL2、ML-CK2,REG4 and so on,have been detected.The article describes the research progress of plasma tumor marker.